The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / New Research Focuses on Bone Erosion and Repair in Rheumatoid Arthritis

New Research Focuses on Bone Erosion and Repair in Rheumatoid Arthritis

June 10, 2012 • By Staff

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Dr. Gravallese
Dr. Gravallese

A research team at the University of Massachusetts Medical School in Worcester has made important findings regarding bone erosion and formation that may lead to better treatment options for people impacted by rheumatoid arthritis (RA).

You Might Also Like
  • ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies
  • Clues Emerge to Bone Health, Destruction in Rheumatoid Arthritis
  • Rethink Rheumatoid Arthritis Research
Explore This Issue
June 2012
Also By This Author
  • 2009 Annual Meeting Goes Beyond the Basics for Basic Researchers

Ellen Gravallese, MD, rheumatology division chief and professor of medicine and cell biology at the University of Massachusetts, received a two-year disease-targeted research grant from the ACR Research and Education Foundation in 2008 to study how osteoclasts and osteoblasts affect bone erosion and healing in RA.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Her lab had previously published studies identifying osteoclasts as cell types involved in bone erosion in patients with RA. In addition, her team had identified receptor activator of NF-κB ligand in synovial tissue as an important factor driving osteoclast differentiation in arthritis. With the clinical use of disease-modifying and biologic agents, rheumatologists observed that the osteoclast-mediated erosive process could be retarded or even arrested. However, there was little evidence of new bone formation. “There was no further erosion, but it’s rare to see bone repair,” says Dr. Gravallese. “In normal bone remodeling, osteoblasts would fill in bone that had been lost or removed.”

With the assistance of the REF grant, Dr. Gravallese’s team decided to focus more closely on osteoblasts. Dr. Gravallese poses the research as a simple question: Once there has been erosion introduced by RA, is it possible to heal the bone?

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“What this work suggests is that when we don’t see bone healing in RA, there may still be inflammation present, even though we don’t recognize it clinically.”

—Ellen Gravallese, MD

Her team tested this question by using the serum transfer arthritis model. Mice were injected with arthritogenic serum, leading to inflammation and bone erosion. After the injections were stopped, the inflammation would begin to disappear. But would the bones heal?

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

“When inflammation was at its peak, very little bone was being laid down,” says Dr. Gravallese. “But as the inflammation resolved, we began to see bone formation at prior inflammation–bone interfaces.”

Peak inflammation occurred around Day 10 after the initial serum transfer. By Day 21, mature osteoblasts began to enter the site of erosion. By Day 28, bone formation was observed, and the bone continued to repair over the next several weeks. “What we found,” says Dr. Gravallese, “is that as inflammation resolves, you see that bone can be formed at that site. What this work suggests is that when we don’t see bone healing in RA, there may still be inflammation present, even though we don’t recognize it clinically.”

Pages: 1 2 | Single Page

Filed Under: Conditions, From the College, Research Reviews, Rheumatoid Arthritis Tagged With: AC&R, American College of Rheumatology, bone, bone erosion, patient care, RA, Research, Rheumatoid arthritis, Rheumatology Research FoundationIssue: June 2012

You Might Also Like:
  • ACR/ARHP Annual Meeting 2012: New Insights into Bone Erosion and Formation Heighten Prospects for Therapies
  • Clues Emerge to Bone Health, Destruction in Rheumatoid Arthritis
  • Rethink Rheumatoid Arthritis Research
  • Osteoimmunology Research May Benefit Patients with Rheumatoid Arthritis

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)